Bora Gurel

15PUBLICATIONS
222CO-AUTHORS
Predictive and prognostic markersTumour immunologyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|May 11, 2026
Immune Spatial Organization Predicts Distant Metastasis Risk in Aggressive Localized Prostate Cancer.

|Apr 27, 2026
Phase I Trial of Ipatasertib plus Atezolizumab Enhances PI3K/AKT Pathway Immune Responses in Solid Tumors and Refractory Glioblastoma.

|Oct 08, 2025
Elucidating molecularly stratified single agent, and combination, therapeutic strategies targeting MCL1 for lethal prostate cancer.

Juan M Jiménez-Vacas, Daniel Westaby, Ines Figueiredo

|Jun 27, 2025
Defactinib with avutometinib in patients with solid tumors: the phase 1 FRAME trial.

Susana Banerjee, Matthew G Krebs, Alastair Greystoke

|May 28, 2025
BH3 mimetics targeting BCL-XL have efficacy in solid tumors with RB1 loss and replication stress.

Andreas Varkaris, Keshan Wang, Mannan Nouri

|Jan 09, 2025
NXP800 Activates the Unfolded Protein Response, Altering AR and E2F Function to Impact Castration-Resistant Prostate Cancer Growth.

Jonathan Welti, Denisa Bogdan, Ines Figueiredo

Pageof 3

Frequent Collaborators

13 joint publications

Johann S de Bono

7 joint publications

Mateus Crespo

6 joint publications

Jan Rekowski

6 joint publications

Ruth Riisnaes